Open in interactive viewer → charts, metric popovers & call review

Legacy Education: A Record Class, a Legal Bill, and an Acquisition That Will Not Close

Record enrollment and 3.1% revenue growth somehow produced a 63% EPS cut — a $687,500 unmodeled settlement, deliberately front-loaded costs, and a starts decline that the calendar, not the funnel, explains.
LGCY · Earnings Call · 2026-11-12

Legacy Education's fiscal first quarter of 2027 is a lesson in how fast an income statement can diverge from a classroom. Enrollment hit a record 3,684 students, up 5.4% year over year and 9.1% sequentially. Revenue rose 3.1% to $20 million. And yet operating income fell to $0.9 million from $2.7 million, diluted EPS dropped to $0.06 from $0.16, and adjusted EBITDA margin compressed to 10.4% from 15.9%. The stock has already voted: down roughly 30% over the last 90 trading days and 42.8% below its March peak of $14.33, in a straight-line decline with no bounce. For a $105 million market-cap vocational educator, that is a name in motion — just not in the direction management would like.

The $687,500 that was not in the model

Three cost buckets explain the quarter, and only one of them is genuinely surprising. First, roughly $1 million of deliberately pulled-forward spending on faculty, staffing, facilities and program development — the "investing ahead of revenue" story management has been telling for several quarters. Second, about $400,000 of first-quarter seasonal audit and legal fees. Third, an unprojected estimated legal settlement of $687,500, which management conceded was not in the plan.

Excluding the estimated legal settlement, our operating income would have been $1.6 million and in line with our expectations... our operating margin is 7.8% compared to 13.9% a year ago, again, in line with expectations.

Brandon Pope, Chief Financial Officer · 2026-11-12

Note what that admission actually says. Strip out the settlement entirely and the margin still halved, from 13.9% to 7.8%. "In line with expectations" is doing a lot of work there — it means the compression is the plan, not the accident. The accident is the settlement, and investors should treat it as a one-off until told otherwise. Some of the cost pressure is structural and timing-driven: the second phase of Wildomar began accruing occupancy costs on July 1 while city permits delayed instructional use, so Legacy paid for space it could not yet fill. Effective SG&A has compounded roughly 96% over two years, against total revenue growth of 88% across the same window — a business spending to build capacity it has not yet filled.

The seasonality defense is credible but old news. On the September 2025 call, the CFO already flagged that "there's some seasonality in that in professional fees that relates to legal, regulatory, audit." Selling the same explanation a year later is consistent, not exculpatory.

Starts: the fog of the academic calendar

The enrollment headline obscured a softer starts quarter. Total starts fell 9.9% to 1,006, with 897 in Title IV programs — down only 5.6%. Management's counterfactual is unusually specific: 105 MRI and cardiac sonography starts that were scheduled to begin in the first quarter slipped into October and November because accreditor and state approvals pushed the degree-program calendar. Had they landed on time, Title IV starts would have grown about 5.5%.

“This is important because had the 105 MRI and cardiac sonography starts that shifted into the second quarter occurred in the first quarter, Title IV starts would have increased approximately 5.5% year-over-year.” — LeeAnn Rohmann, Chief Executive Officer · 2026-11-12

There is a genuine disclosure win buried in the same paragraph. Cash pay programs accounted for just 1.3% of first-quarter revenue but more than half of the year-over-year decline in total starts — a class of short, cheap courses that makes the headline starts number look far worse than the revenue-generating core. Meanwhile the medical-support engine is compounding: ultrasound technician, sterile processing and Surgical Technology generated 338 new starts versus 172 a year earlier.

Vocational nursing: the deliberate trade

The most interesting admission on the call was a self-inflicted wound with a visible payoff. Legacy tightened admissions into vocational nursing — a new entrance exam in November 2025 and a curriculum revamp ahead of the NCLEX-PN — and that discipline cost 264 starts against original expectations over three quarters. What it bought: a 42% improvement in vocational-nursing attrition over 18 months, and an 85.7% first-time NCLEX-PN pass rate over the trailing twelve months (88.5% in the September quarter alone; 92.3% at Lancaster, the largest program).

This is the rare case where a declining starts number is a quality decision rather than a demand problem, and it deserves to be modeled that way. The tension is that nursing remains one of Legacy's top five programs, so a structurally smaller funnel has real revenue consequences even if the graduates are better.

Houston is real; the acquisition is a promise with a history

The capacity build is concrete. Houston — Legacy's first campus outside California — has a signed lease for roughly 28,200 square feet, completed site visits from the Texas Workforce Commission and accreditor ACCET, and 10 approved programs with 7 slated for opening. Management guides to 300 starts in the first half-year of operation and, from the prior call, 400 to 600 students within one to two years. Contra Costa also cleared its change-of-ownership with the Department of Education in November — a fully executed provisional program participation agreement through September 2029 with no letter of credit and no growth restrictions, plus state and accreditor approval for cardiac sonography, MRI and veterinary assisting launching in the second half of fiscal 2027.

The acquisition, however, is the recurring theme that keeps not recurring. On the February 2026 call management expected to "definitely hit that goal of doing this before the end of the fiscal year." By May it was "maintaining my bullish spirit that we're close." By September, "actively under review." This quarter the target is identified and diligence is deep, but the CEO's own words mark the slippage:

“I don't want to overcommit and underdeliver... I would have liked to have seen it before now. But as we're deep -- we are a highly regulated business and deep in due diligence, I shutter to make a commitment.” — LeeAnn Rohmann, Chief Executive Officer · 2026-11-12

Refreshingly honest, but for a serial acquirer whose growth algorithm depends on it, the fourth consecutive quarter of "close" is a credibility tax. Tellingly, acquisition language has quietly slid out of Legacy's top keyword set this quarter — the narrative has been crowded out by legal settlement and cost-timing language, and EBITDA margin, a top-ranked theme last quarter, has vanished entirely from the top-30. When a company stops talking about margin expansion and starts talking about legal bills, the market notices.

The balance sheet buys time

None of this is a solvency story. Legacy ended September with $21.7 million in cash and minimal debt, effective net cash of about $21 million, up 142% over two years, and roughly $34 million of working capital. Operating cash flow was a modest $0.9 million outflow, driven by the timing of Title IV disbursements and tax payments rather than losses.

The broader career training demand backdrop looks intact — peer reporters in the last week described stronger hiring demand for temp staff and a mix shift toward campus-based nursing. Legacy's problem is not demand. It is the timing gap between capacity it pays for today and students who arrive next year, plus one unmodeled legal bill. The next six weeks matter: Houston approvals expected by end of November, a possible acquisition announcement, and a second quarter that should absorb those 105 displaced imaging starts. If the counterfactual is right, Q2 is where the story gets tested.